17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies

NCT00163020 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Preterm Birth

Interventions

DRUG: 17-alpha-hydroxyprogesterone caproate injectable
DRUG: Placebo

Sponsor

Obstetrix Medical Group